Status:
WITHDRAWN
Kinase Genotyping of Gastro Intestinal Stomach Tumors (GISTs) From Patients Enrolled in Pfizer A6181112 Phase IIIb Trial
Lead Sponsor:
Oregon Health and Science University
Collaborating Sponsors:
Pfizer
Conditions:
Gastrointestinal Neoplasm
Eligibility:
All Genders
18-80 years
Brief Summary
The purpose of this study is to determine the genetic makeup of gastro intestinal stomach tumors (GISTs) from patients enrolled in the A6181112 phase IIIb trial. Tumor samples will be screened for mut...
Detailed Description
In this companion study, we will analyze the genomic DNA from the GIST tumor specimens of patients enrolled in the in the A6181112 phase IIIb trial at participating U.S. and ex-U.S. medical centers. S...
Eligibility Criteria
Inclusion
- Patients enrolled in Pfizer A6181112
Exclusion
- Patients who do not consent for analysis of their tumor in this companion study
Key Trial Info
Start Date :
December 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2011
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00640692
Start Date
December 1 2007
End Date
April 1 2011
Last Update
November 4 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.